These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 20371736)

  • 1. Unexpected effect of rifampin on the pharmacokinetics of linezolid: in silico and in vitro approaches to explain its mechanism.
    Gandelman K; Zhu T; Fahmi OA; Glue P; Lian K; Obach RS; Damle B
    J Clin Pharmacol; 2011 Feb; 51(2):229-36. PubMed ID: 20371736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients.
    Sasaki T; Takane H; Ogawa K; Isagawa S; Hirota T; Higuchi S; Horii T; Otsubo K; Ieiri I
    Antimicrob Agents Chemother; 2011 May; 55(5):1867-73. PubMed ID: 21357301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a rifampicin pre-treatment on linezolid pharmacokinetics.
    Okazaki F; Tsuji Y; Seto Y; Ogami C; Yamamoto Y; To H
    PLoS One; 2019; 14(9):e0214037. PubMed ID: 31518346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of intravenous linezolid in moderately to morbidly obese adults.
    Bhalodi AA; Papasavas PK; Tishler DS; Nicolau DP; Kuti JL
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1144-9. PubMed ID: 23254421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifampin reduces concentrations of trimethoprim and sulfamethoxazole in serum in human immunodeficiency virus-infected patients.
    Ribera E; Pou L; Fernandez-Sola A; Campos F; Lopez RM; Ocaña I; Ruiz I; Pahissa A
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3238-41. PubMed ID: 11600390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased serum linezolid concentrations in two patients receiving linezolid and rifampicin due to bone infections.
    Hoyo I; Martínez-Pastor J; Garcia-Ramiro S; Climent C; Brunet M; Cuesta M; Mensa J; Soriano A
    Scand J Infect Dis; 2012 Jul; 44(7):548-50. PubMed ID: 22385321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of pharmacokinetic target attainment and hematological toxicity of linezolid in pediatric patients.
    Abouelkheir M; Aldawsari MR; Ghonem L; Almomen A; Alsarhani E; Alsubaie S; Alqahtani S; Kurdee Z; Alsultan A
    Eur J Clin Pharmacol; 2024 Aug; ():. PubMed ID: 39183194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of drug-drug interaction on linezolid pharmacokinetics: A systematic review.
    Xu Q; Sang Y; Gao A; Li L
    Eur J Clin Pharmacol; 2024 Jun; 80(6):785-795. PubMed ID: 38421436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the incidence of nausea and vomiting between linezolid and vancomycin using claims database: a retrospective cohort study.
    Tsutsumi T; Imai S; Momo K; Kashiwagi H; Sato Y; Sugawara M; Takekuma Y
    Int J Clin Pharm; 2024 Apr; 46(2):421-428. PubMed ID: 38158470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the impact of rifampicin on the plasma concentration of linezolid in tuberculosis co-infected patients.
    Yan P; Shi QZ; Hu YX; Zeng Y; Lu H
    Front Pharmacol; 2023; 14():1260535. PubMed ID: 38026932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linezolid Population Pharmacokinetic Model in Plasma and Cerebrospinal Fluid Among Patients With Tuberculosis Meningitis.
    Abdelgawad N; Wasserman S; Abdelwahab MT; Davis A; Stek C; Wiesner L; Black J; Meintjes G; Wilkinson RJ; Denti P
    J Infect Dis; 2024 Apr; 229(4):1200-1208. PubMed ID: 37740554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-Stage Revision Arthroplasty for Resistant Gram-Positive Periprosthetic Joint Infections Using an Oral Linezolid-Based Antibiotic Regime.
    Gründer L; Bockholt S; Gosheger G; Schulze M; Schwarze J; Pützler J; Moellenbeck B; Theil C
    Antibiotics (Basel); 2023 Jul; 12(8):. PubMed ID: 37627655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful Treatment of
    Kohm K; Seneca K; Smith K; Heinemann D; Nahass RG
    Open Forum Infect Dis; 2023 Aug; 10(8):ofad370. PubMed ID: 37539065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically-Based Pharmacokinetic Modelling to Predict the Pharmacokinetics and Pharmacodynamics of Linezolid in Adults and Children with Tuberculous Meningitis.
    Litjens CHC; Verscheijden LFM; Svensson EM; van den Broek PHH; van Hove H; Koenderink JB; Russel FGM; Aarnoutse RE; Te Brake LHM
    Antibiotics (Basel); 2023 Apr; 12(4):. PubMed ID: 37107064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do Anti-Biofilm Antibiotics Have a Place in the Treatment of Diabetic Foot Osteomyelitis?
    Senneville E; Gachet B; Blondiaux N; Robineau O
    Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Japanese big data from electronic medical records to investigate risk factors and identify their high-risk combinations for linezolid-induced thrombocytopenia.
    Inoue Y; Takekuma Y; Miyai T; Kashiwagi H; Sato Y; Sugawara M; Imai S
    Eur J Clin Pharmacol; 2023 Mar; 79(3):415-425. PubMed ID: 36715711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): study protocol for a phase III randomized controlled trial.
    Maitre T; Bonnet M; Calmy A; Raberahona M; Rakotoarivelo RA; Rakotosamimanana N; Ambrosioni J; Miró JM; Debeaudrap P; Muzoora C; Davis A; Meintjes G; Wasserman S; Wilkinson R; Eholié S; Nogbou FE; Calvo-Cortes MC; Chazallon C; Machault V; Anglaret X; Bonnet F
    Trials; 2022 Nov; 23(1):928. PubMed ID: 36348453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of Population Pharmacokinetic Analyses of Linezolid.
    Bandín-Vilar E; García-Quintanilla L; Castro-Balado A; Zarra-Ferro I; González-Barcia M; Campos-Toimil M; Mangas-Sanjuan V; Mondelo-García C; Fernández-Ferreiro A
    Clin Pharmacokinet; 2022 Jun; 61(6):789-817. PubMed ID: 35699914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDR Tuberculosis Treatment.
    Espinosa-Pereiro J; Sánchez-Montalvá A; Aznar ML; Espiau M
    Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis and pharmacological interactions: A narrative review.
    Riccardi N; Canetti D; Rodari P; Besozzi G; Saderi L; Dettori M; Codecasa LR; Sotgiu G
    Curr Res Pharmacol Drug Discov; 2021; 2():100007. PubMed ID: 34909643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.